SARS-CoV-2 Variants Identification: Overview of Molecular Existing Methods
- PMID: 36145490
- PMCID: PMC9504725
- DOI: 10.3390/pathogens11091058
SARS-CoV-2 Variants Identification: Overview of Molecular Existing Methods
Abstract
Since the beginning of COVID-19 pandemic the Real Time sharing of genome sequences of circulating virus supported the diagnostics and surveillance of SARS-CoV-2 and its transmission dynamics. SARS-CoV-2 straightaway showed its tendency to mutate and adapt to the host, culminating in the emergence of variants; so it immediately became of crucial importance to be able to detect them quickly but also to be able to monitor in depth the changes on the whole genome to early identify the new possibly emerging variants. In this scenario, this manuscript aims to provide an overview of the existing methods for the identification of SARS-CoV-2 variants (from rapid method based on identification of one or more specific mutations to Whole Genome sequencing approach-WGS), taking into account limitations, advantages and applications of them in the field of diagnosis and surveillance of SARS-CoV-2.
Keywords: COVID-19; SARS-CoV-2; SARS-CoV-2 pandemic; rapid methods; sequencing; surveillance; variants characterization.
Conflict of interest statement
The authors have no conflict of interest to declare that are relevant to the content of this article.
Figures


References
-
- World Health Organization (WHO) WHO Coronavirus (COVID-19) Dashboard. [(accessed on 26 August 2022)]. Available online: https://covid19.who.int/
-
- Mohammadi E., Shafiee F., Shahzamani K., Ranjbar M.M., Alibakhshi A., Ahangarzadeh S., Beikmohammadi L., Shariati L., Hooshmandi S., Ataei B., et al. Novel and emerging mutations of SARS-CoV-2: Biomedical implications. Biomed. Pharmacother. 2021;139:111599. doi: 10.1016/j.biopha.2021.111599. Erratum in Biomed. Pharmacother. 2021, 140, 111723. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous